Remove launches
article thumbnail

Outrun Therapeutics announces launch with $10m seed funding

Pharmaceutical Technology

Outrun Therapeutics announced its launch with $10m seed funding to advance a protein stabilisation pipeline focused on E3 ligase inhibitors.

129
129
article thumbnail

Aduhelm and an expensive failure to launch

pharmaphorum

Learn more about the expensive failure to launch of these medications. Aduhelm (aducanumab) and Leqembi are examples of controversial drugs that faced challenges with FDA approval.

FDA 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PureTech Health launches Seaport Therapeutics

Pharmafile

This includes the launch of Seaport Therapeutics with $100m oversubscribed series A financing. This financing round included participation from ARCH Venture Partners, Sofinnova Investments and Third Rock Ventures, with […] The post PureTech Health launches Seaport Therapeutics appeared first on Pharmafile.

59
article thumbnail

WebMD Ignite launches new member engagement platform for payers

Fierce Healthcare

WebMD Ignite is launching a new suite of tech tools it says will help payers turbocharge their clinical programs. WebMD Ignite is launching a new suite of tech tools it says will help payers turbocharge their clinical programs.

68
article thumbnail

ViVE 2024: Simple HealthKit launches new kidney disease testing program

Fierce Healthcare

LOS ANGELES — Simple HealthKit is launching a new kidney care program that aims to support health plans in driving better outcomes. | LOS ANGELES — Simple HealthKit is launching a new kidney care program that aims to support health plans in driving better outcomes.

121
121
article thumbnail

STAT+: Biogen’s Alzheimer’s drug launch on ‘steady pace’ as logistical hurdles recede

STAT

Total revenue was slightly weak overall, but sales were stronger for two newly launched medicines — Leqembi and Skyclarys — that matter most to the biotech’s turnaround effort. Biogen on Wednesday reported first-quarter earnings that beat Wall Street expectations largely on reduced expenses.

103
103
article thumbnail

Cedars-Sinai mental health app launches on Apple Vision Pro

pharmaphorum

Right after the official launch of the new Apple Vision Pro mixed reality headset, Cedars-Sinai has launched a generative artificial intelligence (genAI) app that will use the technology to provide mental health support for patients.

113
113